Virus-Drug Nod Spurs Record Rally in India’s Glenmark Pharma

(Bloomberg) -- Shares of India’s Glenmark Pharmaceutical Ltd. climbed the most on record after it received approval to manufacture and sell a coronavirus treatment.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.